216 related articles for article (PubMed ID: 9627715)
1. Shifts in cadherin profiles between human normal melanocytes and melanomas.
Hsu MY; Wheelock MJ; Johnson KR; Herlyn M
J Investig Dermatol Symp Proc; 1996 Apr; 1(2):188-94. PubMed ID: 9627715
[TBL] [Abstract][Full Text] [Related]
2. E-cadherin expression in melanoma cells restores keratinocyte-mediated growth control and down-regulates expression of invasion-related adhesion receptors.
Hsu MY; Meier FE; Nesbit M; Hsu JY; Van Belle P; Elder DE; Herlyn M
Am J Pathol; 2000 May; 156(5):1515-25. PubMed ID: 10793063
[TBL] [Abstract][Full Text] [Related]
3. Cadherin expression pattern in melanocytic tumors more likely depends on the melanocyte environment than on tumor cell progression.
Krengel S; Grotelüschen F; Bartsch S; Tronnier M
J Cutan Pathol; 2004 Jan; 31(1):1-7. PubMed ID: 14675278
[TBL] [Abstract][Full Text] [Related]
4. Ca2+ and UVB radiation have no effect on E-cadherin-mediated melanocyte-keratinocyte adhesion.
Nakazawa K; Nakazawa H; Bonnard M; Damour O; Collombel C
Pigment Cell Res; 1995 Oct; 8(5):255-62. PubMed ID: 8789200
[TBL] [Abstract][Full Text] [Related]
5. Downregulation of E-cadherin and Desmoglein 1 by autocrine hepatocyte growth factor during melanoma development.
Li G; Schaider H; Satyamoorthy K; Hanakawa Y; Hashimoto K; Herlyn M
Oncogene; 2001 Dec; 20(56):8125-35. PubMed ID: 11781826
[TBL] [Abstract][Full Text] [Related]
6. Identification of novel cadherins expressed in human melanoma cells.
Matsuyoshi N; Tanaka T; Toda K; Imamura S
J Invest Dermatol; 1997 Jun; 108(6):908-13. PubMed ID: 9182820
[TBL] [Abstract][Full Text] [Related]
7. E-cadherin/catenin complex in benign and malignant melanocytic lesions.
Silye R; Karayiannakis AJ; Syrigos KN; Poole S; van Noorden S; Batchelor W; Regele H; Sega W; Boesmueller H; Krausz T; Pignatelli M
J Pathol; 1998 Dec; 186(4):350-5. PubMed ID: 10209482
[TBL] [Abstract][Full Text] [Related]
8. The role of cadherin/catenin complex in malignant melanoma.
Bonitsis N; Batistatou A; Karantima S; Charalabopoulos K
Exp Oncol; 2006 Sep; 28(3):187-93. PubMed ID: 17080010
[TBL] [Abstract][Full Text] [Related]
9. E-cadherin expression in human melanoma.
Danen EH; de Vries TJ; Morandini R; Ghanem GG; Ruiter DJ; van Muijen GN
Melanoma Res; 1996 Apr; 6(2):127-31. PubMed ID: 8791270
[TBL] [Abstract][Full Text] [Related]
10. Subtypes of melanocytes and melanoma cells distinguished by their intercellular contacts: heterotypic adherens junctions, adhesive associations, and dispersed desmoglein 2 glycoproteins.
Rickelt S; Franke WW; Doerflinger Y; Goerdt S; Brandner JM; Peitsch WK
Cell Tissue Res; 2008 Dec; 334(3):401-22. PubMed ID: 18975006
[TBL] [Abstract][Full Text] [Related]
11. Reversal of melanocytic malignancy by keratinocytes is an E-cadherin-mediated process overriding beta-catenin signaling.
Li G; Fukunaga M; Herlyn M
Exp Cell Res; 2004 Jul; 297(1):142-51. PubMed ID: 15194432
[TBL] [Abstract][Full Text] [Related]
12. Cadherin expression in melanocytic naevi and malignant melanomas.
Cowley GP; Smith ME
J Pathol; 1996 Jun; 179(2):183-7. PubMed ID: 8758211
[TBL] [Abstract][Full Text] [Related]
13. Regulation of Mel-CAM/MUC18 expression on melanocytes of different stages of tumor progression by normal keratinocytes.
Shih IM; Elder DE; Hsu MY; Herlyn M
Am J Pathol; 1994 Oct; 145(4):837-45. PubMed ID: 7943174
[TBL] [Abstract][Full Text] [Related]
14. E-cadherin is the major mediator of human melanocyte adhesion to keratinocytes in vitro.
Tang A; Eller MS; Hara M; Yaar M; Hirohashi S; Gilchrest BA
J Cell Sci; 1994 Apr; 107 ( Pt 4)():983-92. PubMed ID: 8056851
[TBL] [Abstract][Full Text] [Related]
15. Expression of E and P-cadherin by melanoma cells decreases in progressive melanomas and following ultraviolet radiation.
Seline PC; Norris DA; Horikawa T; Fujita M; Middleton MH; Morelli JG
J Invest Dermatol; 1996 Jun; 106(6):1320-4. PubMed ID: 8752677
[TBL] [Abstract][Full Text] [Related]
16. Normal human melanocyte homeostasis as a paradigm for understanding melanoma.
Haass NK; Herlyn M
J Investig Dermatol Symp Proc; 2005 Nov; 10(2):153-63. PubMed ID: 16358819
[TBL] [Abstract][Full Text] [Related]
17. A secreted form of P-cadherin is expressed in malignant melanoma.
Bauer R; Hein R; Bosserhoff AK
Exp Cell Res; 2005 May; 305(2):418-26. PubMed ID: 15817166
[TBL] [Abstract][Full Text] [Related]
18. H-cadherin expression reduces invasion of malignant melanoma.
Kuphal S; Martyn AC; Pedley J; Crowther LM; Bonazzi VF; Parsons PG; Bosserhoff AK; Hayward NK; Boyle GM
Pigment Cell Melanoma Res; 2009 Jun; 22(3):296-306. PubMed ID: 19368692
[TBL] [Abstract][Full Text] [Related]
19. Melanocyte migration is influenced by E-cadherin-dependent adhesion of keratinocytes in both two- and three-dimensional in vitro wound models.
Keswell D; Kidson SH; Davids LM
Cell Biol Int; 2015 Feb; 39(2):169-76. PubMed ID: 25052848
[TBL] [Abstract][Full Text] [Related]
20. SPARC represses E-cadherin and induces mesenchymal transition during melanoma development.
Robert G; Gaggioli C; Bailet O; Chavey C; Abbe P; Aberdam E; Sabatié E; Cano A; Garcia de Herreros A; Ballotti R; Tartare-Deckert S
Cancer Res; 2006 Aug; 66(15):7516-23. PubMed ID: 16885349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
